Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Hua Han Bio-Pharma and China National Biotec Announce JV

publication date: Apr 23, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
A subsidiary of Hua Han Bio-Pharmaceutical Holdings, Guizhou Factorr Bio-Technology Co., signed a framework agreement to set up a JV with National Vaccine & Serum Institute. NVSI is a Beijing-based company that is part of the China National Biotec Group. Guizhou will fund the JV with between 30 and 50 million RMB of capital ($5-8 million), while NVSI will contribute rights to three biopharma products. More details....

Stock Symbol: (HK: 00587)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...